As part of an ongoing commitment to invest in the local community, award-winning, sustainable plantation management company, Asia Plantation Capital Berhad (APCB), was proud to support the IIUM Engineering Congress 2016 (IEC’16) which was held from the 25th to the 27th of July 2016, at the International Islamic University Malaysia (IIUM) in Kuala Lumpur, Malaysia.
The Congress aims to provide an international platform and technical forum for engineers, academicians, scientists and researchers to share/exchange ideas and knowledge on their current research and future endeavours. The fields of study and examination include Biotechnology Engineering, Electronics, Computer and Communication Engineering, and Mechanical and Aerospace Engineering.
Embracing the theme, ‘harnessing biotechnology for a sustainable and green future’, Dr Yumi Z Has-Yun Hashim, Asia Plantation Capital’s Scientific Board advisor and an Associate Professor at the IIUM Kulliyyah of Engineering, presented her research paper on Agarwood – entitled ‘The Cytokinetic Study of Uninfected Agarwood Branch Ethanolic Extract on Breast Cancer Cells’ – in the Biotechnology Engineering category of the Congress.
The objective of the paper was to examine the application of Agarwood as a treatment for a variety of ailments, including inflammatory-related diseases and cancer, and its efficacy in relation to certain drugs. Conclusions were based on reaction times, as well as the paucity of side effects that Agarwood presented. The study also proves a kinetic reaction of Agarwood to diseases.
Also present at the congress to showcase his findings was Professor Dr Mamoun Bader, Professor of Chemistry at Alfaisal University, Saudi Arabia. The sustainable production of Agarwood and all its associated products lies at the heart of everything Asia Plantation Capital strives to do, and the company was honoured to share its findings not only with the keynote speaker Dr Bader, but also with the Chairman of IEC’16, Prof Emeritus Dato’ Wira Ir Dr Mohd Noor Salleh.
Besides investing heavily in the expansion of its operations in Malaysia, Asia Plantation Capital Berhad is also focusing future plans on the funding for medical research, particularly with respect to the potential health benefits of Agarwood.